Module #1 - Biopharm Industry Flashcards
(85 cards)
4 main types of pharmaceutical companies
ethical
generic
biotech
contract research organizations
characteristics of ethical companies (3)
research heavy
discover new molecular entities
very large
characteristics of generic companies (5)
research limited
focused on manufacturing and breaking/adapting patents
don’t discover new molecular entities
large to medium sized
market products no longer protected by patents
characteristics of biotech companies (4)
exploit academic discoveries
smaller
specialty products
research intensive
characteristics of contract research organizations (4)
provide specialty services for pharmaceutical companies (ex. testing, manufacturing, clinical trials, etc.)
small to medium sized
low risk because they don’t have to worry about drug failing
hired by big companies
what is the drug product database?
health Canada
contains data on over 47000 products
what are molecular entities (drugs) (4)
active ingredient in drug products
pure ingredient
small molecule or biologic
produce the effects of the product
what are drug products (2)
materials that contain a molecular entity
formulation of a drug
how many molecular entities approved each year? how many of those are small molecules?
40 entitites
30 small molecules
are small molecules or biologic molecules more common? trends?
small molecules more common
but trend for biologic molecules due to newer technologies
what are the five major phases of drug development?
discovery
development
clinical trails
FDA approval
market
describe the discovery phase of drug development (time, goals, and end product)
1-3 years
start with an idea + discover a new molecular entity (drug candidate)
end product = drug candidate
describe the development phase of drug development (time, goals, and end product)
1-2 years
turn drug candidate into a potentially sellable product
end product = investigational new drug
describe the clinical trial phase of drug development (time, goals, and end product)
1-5 years
test investigational new drug for safety, establish safe dosing limits, test for efficacy, test for rare side effects, etc.
end product = new drug application
describe the FDA approval phase of drug development (time, goals, and end product)
6 months to 1.5 years
review data from clinical trials, make sure benefits outweigh risks
end product = market approval
describe the market phase of drug development (time, goals, and end product)
unlimited time
make money, continue safety testing (rare side effects could occur because bigger test group)
end product = $$$
what is a drug candidate? (6)
molecular entity that could potentially be a drug
identified in the discovery process
structure kept secret
no approval necessary to discover this
lots of synthesis/testing and gene expression/protein isolation
used to create investigational new drug
what is an investigational new drug (4)
the product that results from the drug candidate
is an application made to the FDA to enter clinical trials
includes data: pharmacology + toxicity data from animal studies, and manufacturing info
includes plan on how clinical trials on humans will take place
what is a new drug application (3)
application made to FDA to enter the market during the clinical trials
includes full data: efficacy, safety, dosing, labelling, results of clinical trials + animal experiments, manufacturing methods etc.
application must show that benefits outweigh risks
what is an abbreviated new drug application
an application made to the FDA by generic drug companies to allow generic drug to enter market
must show that product does same thing as name brand product
shows drug identity, formulation, route of administration, dosing, performance, etc.
what are the 3 main steps of project initiation (3) (not official step)
market analysis
competitive assessment
research analysis
what is involved in market analysis stage of project initiation (3)
assess number/nature of customers (able to pay? lots of people?)
assess nature of disease (chronic? life threatening?)
focus groups take place + literature is observed to see if product will sell
why do drug companies prefer chronic conditions?
because long-term, not just one and done - more money can be made
what is involved in the competitive assessment stage of project initiation (3)
patent literature observed to see what competition is like and what other companies are doing
want to be one of first 3 drugs on the market